🔎 Trials Near Me

Hem › Sickelcellssjukdom › Georgia › Atlanta

Kliniska studier för Sickelcellssjukdom i Atlanta, GA

22 studier för Sickelcellssjukdom söker deltagare vid platser i och runt Atlanta (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

RekryterarFas 1
  • Emory University, Atlanta
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT07187973

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

RekryterarFas 3
  • WCG Sonar Clinical Research, Riverdale · 12 mi bort
Ålder 12 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT06439082

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

RekryterarFas 3
  • Children's Healthcare Atlanta, Atlanta
Ålder 2 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT06609226

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

RekryterarFas 3
  • Children's Healthcare Atlanta, Atlanta
Ålder 12 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06612268

Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing

Rekryterar
  • Children's Healthcare of Atlanta, Atlanta
Ålder 8 till 18 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07562451

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

RekryterarFas 2/3
  • Children's Center for Advanced Pediatrics, Atlanta
Ålder 12 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT05431088

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

RekryterarFas 1/2Friska volontärer välkomna
  • Winship Cancer Institute of Emory University, Atlanta
Ålder 18 och äldre · Alla kön · Uppdaterad 18 aug. 2026 · NCT06481306

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

RekryterarObservationsstudie
  • Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta
  • Emory/Children's Health Care of Atlanta, Atlanta
Alla åldrar · Alla kön · Uppdaterad 17 aug. 2026 · NCT04398628

Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis

RekryterarFas 2
  • Arthur M. Blank Hospital-Children's Healthcare of Atlanta, Atlanta
Ålder 12 och äldre · Alla kön · Uppdaterad 14 aug. 2026 · NCT06699849

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

RekryterarFas 2
  • Arthur M. Blank Hospital- Children's Healthcare of Atlanta, Atlanta
Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT07224360

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

RekryterarFas 1/2
  • Children's Healthcare fo Atlanta at Hughes Spalding, Atlanta
  • Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta
Ålder 7 till 21 · Alla kön · Uppdaterad 29 juli 2026 · NCT02447874

Cooperative Assessment of Late Effects for SCD Curative Therapies

RekryterarObservationsstudie
  • Emory University School of Medicine, Atlanta
Ålder 4 till 65 · Alla kön · Uppdaterad 27 juli 2026 · NCT05153967

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

RekryterarObservationsstudie
  • Children's Healthcare of Atlanta (MRD-HCT), Atlanta
Ålder 3 till 20 · Alla kön · Uppdaterad 4 juni 2026 · NCT06941389

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

RekryterarFas 1/2
  • Children's Healthcare of Atlanta, Atlanta
Ålder 12 till 45 · Alla kön · Uppdaterad 4 juni 2026 · NCT07252050

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

RekryterarFas 4
  • Emory University, Atlanta
Ålder 18 till 50 · Kvinnor · Uppdaterad 28 maj 2026 · NCT06665997

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

Rekryterar
  • Children's Healthcare of Atlanta, Atlanta
Ålder 13 till 21 · Alla kön · Uppdaterad 11 maj 2026 · NCT06290401

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

RekryterarFas 3
  • Site # 8400006, Atlanta
  • Site # 8400002, Atlanta
Ålder 2 till 17 · Alla kön · Uppdaterad 15 apr. 2026 · NCT07247188

Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease

RekryterarFas 4Friska volontärer välkomna
  • Grady Health System, Atlanta
Ålder 18 och äldre · Kvinnor · Uppdaterad 18 feb. 2026 · NCT06979492

A Long-term Follow-up Study in Patients Who Received BEAM-101

RekryterarObservationsstudie
  • Children's Healthcare of Atlanta - Aflac Cancer and Blood Disorders Center- Egleston, Atlanta
Ålder 14 till 37 · Alla kön · Uppdaterad 28 jan. 2026 · NCT07373639

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

Rekryterar
  • Children's Hospital of Atlanta: Eagelston, Atlanta
Ålder 7 till 18 · Alla kön · Uppdaterad 26 jan. 2026 · NCT07090668

Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain

Rekryterar
  • Children's Healthcare of Atlanta, Atlanta
Ålder 16 till 30 · Alla kön · Uppdaterad 7 jan. 2026 · NCT06374238

Integrative Training Program for Pediatric Sickle Cell Pain

Rekryterar
  • Children's Healthcare of Atlanta, Atlanta
  • Arthur M. Blank Hospital | Children's Healthcare of Atlanta, Atlanta
Ålder 12 till 18 · Alla kön · Uppdaterad 14 nov. 2025 · NCT06691867

Sickelcellssjukdom-studier i andra städer

Andra studier i Atlanta

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.